Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls

Journal of Psychopharmacology

Volumn 29, Issue 8, 2015, Pages 898-902

  Karamustafalioglu, Nesrin ^a   Genc, Abdullah ^a   Kalelioglu, Tevfik ^a   Tasdemir, Akif ^a   Umut, Gokhan ^a   Incir, Said ^b   Akkuş, Mustafa ^a   Emul, Murat ^b  

^a Neurological Disorders   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

atypical antipsychotics; Brain derived neurotropic factor; electroconvulsive therapy (ECT); mania

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HALOPERIDOL; QUETIAPINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; EDUCATIONAL STATUS; ELECTROCONVULSIVE THERAPY; EMPLOYMENT STATUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MANIA; MARRIAGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REMISSION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE; BLOOD; COMPARATIVE STUDY; FEMALE; PROCEDURES;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; ELECTROCONVULSIVE THERAPY; FEMALE; HALOPERIDOL; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUETIAPINE FUMARATE;

EID: 84937891931     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115578161     Document Type: Article

References (26)

1. Altar CA, (1999) Neurotrophins and depression. Trends in Pharmacological Sciences 20 (2): 59-61.
2. American Psychiatric Association (2011) Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsion Therapy, 2nd edn. Washington, DC: American Psychiatric Press.
3. Berwaerts J, Lane R, Nuamah IF,. (2011) Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. J Affect Disord 129: 252-260.
4. Bilgen AE, BozkurtZincir S, Zincir S,. (2014) Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression. Brain Res Bull 104: 82-87.
5. Cunha AB, Frey BN, Andreazza AC,. (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398: 215-219.
6. de Oliveira GS, Cereser KM, Fernandes B,. (2009) Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 43: 1171-1174.
7. de Sousa RT, van de, Bilt MT, Diniz BS,. (2011) Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 494: 54-56.
8. Fernandes BS, Gama CS, Ceresér KM,. (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res 45: 995-1004.
9. Fernandes B, Gama CS, Massuda R,. (2009) Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci Lett 453: 195-198.
10. Grandea I, Kapczinskib F, Stertzb L,. (2012) Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-labeltrial in drug-free patients with bipolar disorder. J Psychiatr Res 46: 1511-1514.
11. Haghighi M, Salehi I, Erfani P,. (2013) Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. J Psychiatr Res 47: 908-915.
12. Horch HW, Kruttgen A, Portbury SD,. (1999) Destabilization of cortical dendrites and spines by BDNF. Neuron 23: 353-364.
13. Hu Y, Yu X, Yang F,. (2010) The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J ECT 26: 121-125.
14. Karadag F, Oral ET, AranYalcin E,. (2002) The validity and reliability of Young Mania Rating Scale in Turkish. Turk Psikiyatri Dergisi 13: 107-114 (in Turkish).
15. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC,. (2009) Brain-derived neurotrophic factor and inflammatory markers in patients with early vs. late stage bipolar disorder. Intl J Neuropsychopharmacol 12: 447-458.
16. Kenna HA, Reynolds-May M, Stepanenko A,. (2014) Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women. J Affect Disord 156: 214-218.
17. Machado-Vieira R, Dietrich MO, Leke R,. (2007) Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61: 142-144.
18. Mikkelsen JD, Woldbye DP, (2006) Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J Psychiatr Res 40: 153-159.
19. Monteleone P, Serritella C, Martiadis V,. (2008) Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord 10: 95-100.
20. Pezet S, Malcangio M, (2004) Brain-derived neurotrophic factor as a drug target for CNS disorders. Exp Opin Therapeut Targets 8: 391-399.
21. Rabie MA, Mohsen M, Ibrahim M,. (2014) Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder. J Affect Disord 162: 67-72.
22. Tolwani RJ, Buckmaster PS, Varma S,. (2002) BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience 114: 795-805.
23. Tramontina JF, Andreazza AC, Kauer-Sant'Anna M,. (2009) Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett 452: 111-113.
24. Yoshida T, Ishikawa M, Niitsu T,. (2012) Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 7: e42676.
25. Yoshimura R, Nakano Y, Hori H,. (2006) Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factorin patients with bipolar disorders. Hum Psychopharmacol 21: 433-438.
26. Young RC, Biggs JT, Ziegler VE,. (1978) A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133: 429-435.